Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women.

Background: To assess the effect of a 12-day treatment using a vaginal gel based on niosomes containing hyaluronic acid, ß-glucan, alpha-glucan oligosaccharide, Coriolus versicolor, Asian centella, Azadirachta indica and Aloe vera on vaginal microbiota, cervical epithelization and vaginal health.Met...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Women's Health Vol. 17; pp. 1 - 7
Autores principales: Palacios, Santiago, Losa, Fernando, Dexeus, Damián, Cortés, Javier
Formato: clinical trial pictorial research tables/charts Journal Article
Publicado: BioMed Central 3/16/2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=122000231&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 122000231
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14726874
        1CIP
      jtl: BMC Women's Health
      issn: 14726874
      maglogo: N
    pubinfo:
      dt: 3/16/2017
      vid: 17
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        122000231
        122000231
        NLM28302110
        122000231
        10.1186/s12905-017-0374-2
        NLM28302110
        122000231
      ppf: 1
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women.
      aug:
        au:
          Palacios, Santiago
          Losa, Fernando
          Dexeus, Damián
          Cortés, Javier
        affil: Gynecology and Obstetrics Department, Instituto Palacios de Medicina y Salud de la Mujer, C/Antonio Acuña 9, E-28009 Madrid, Spain
      sug:
        subj:
          Vaginal Creams, Foams and Jellies Pharmacodynamics
          Vagina Microbiology
          Adult
          Spain
          Colposcopy Methods
          Microbiologic Phenomena Drug Effects
          Mucus Microbiology
          Pilot Studies
          Vaginal Creams, Foams and Jellies Administration and Dosage
          Vaginal Creams, Foams and Jellies Therapeutic Use
          Lactobacillus
          Data Analysis, Statistical
          Prospective Studies
          Female
          Clinical Trials
          Human
          Adult: 19-44 years
          Female
      ab: Background: To assess the effect of a 12-day treatment using a vaginal gel based on niosomes containing hyaluronic acid, ß-glucan, alpha-glucan oligosaccharide, Coriolus versicolor, Asian centella, Azadirachta indica and Aloe vera on vaginal microbiota, cervical epithelization and vaginal health.Methods: Open-label, prospective pilot study conducted in asymptomatic women in daily practice. Cervical epithelization was evaluated by colposcopy using an ectopy epithelization score (from 5: no ectopy to 1: severe ectopy and bleeding), vaginal microbiota using the VaginaStatus-Diagnostic test (Instiüt für Mikroökologie, Herborn, Germany) and further rated by the investigator using a 5-point Liker scale (from 5: normal to 1: very severe deterioration in which all evaluated species were altered), and vaginal health using the Vaginal Health Index.Results: In 21 women, a positive effect to improve epithelization of the cervical mucosa, with a mean score of 4.42 at the final visit as compared to 3.09 at baseline (P < 0.0001) (43% improvement). In 10 women, there was a trend of improving of vaginal microbiota status, with a mean score of 4.0 at the final visit vs. 3.3 at baseline (P = NS) (21.2% improvement). In 11 women, the Vaginal Health Index increased from 19.0 at baseline to 22.3 at the final visit (P = 0.007). The concentration of Lactobacillus spp. increased 54.5% of women and pH decreased from 4.32 to 4.09.Conclusions: These encouraging preliminary results provide the basis for designing a randomized controlled study, and for potential use in human papilloma virus infection.Trial Registration: ISRCTN77955077 . Registration date: February 15, 2017. Retrospectively registered.
      pubtype: Academic Journal
      doctype:
        clinical trial
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N